These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32247874)

  • 1. Primary imputation methods impact efficacy results in hidradenitis suppurativa clinical trials.
    Frew JW
    J Am Acad Dermatol; 2020 Aug; 83(2):663-665. PubMed ID: 32247874
    [No Abstract]   [Full Text] [Related]  

  • 2. A systematic review finds variable use of the intention-to-treat principle in musculoskeletal randomized controlled trials with missing data.
    Joseph R; Sim J; Ogollah R; Lewis M
    J Clin Epidemiol; 2015 Jan; 68(1):15-24. PubMed ID: 25304501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Missing data handling in chronic pain trials.
    Kim Y
    J Biopharm Stat; 2011 Mar; 21(2):311-25. PubMed ID: 21391004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dropouts and missing data in psychiatric clinical trials.
    Potkin SG; Siu CO
    Am J Psychiatry; 2009 Nov; 166(11):1295; author reply 1295-6. PubMed ID: 19884237
    [No Abstract]   [Full Text] [Related]  

  • 5. Statistics Commentary Series: Commentary #10-Dealing With Drop-Outs.
    Streiner DL
    J Clin Psychopharmacol; 2015 Oct; 35(5):496-8. PubMed ID: 25803367
    [No Abstract]   [Full Text] [Related]  

  • 6. Testing for treatment differences with dropouts present in clinical trials--a composite approach.
    Troendle JF
    Stat Med; 1998 May; 17(9):1062-4. PubMed ID: 9612891
    [No Abstract]   [Full Text] [Related]  

  • 7. Consensus on the treatment of hidradenitis suppurativa - Brazilian Society of Dermatology.
    Magalhães RF; Rivitti-Machado MC; Duarte GV; Souto R; Nunes DH; Chaves M; Hirata SH; Ramos AMC
    An Bras Dermatol; 2019 Apr; 94(2 Suppl 1):7-19. PubMed ID: 31166401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient-reported outcomes in hidradenitis suppurativa.
    Vellaichamy G; Braunberger TL; Jones JL; Peacock A; Nahhas AF; Hamzavi IH
    G Ital Dermatol Venereol; 2019 Apr; 154(2):137-147. PubMed ID: 30375207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hidradenitis Suppurativa: A Systematic Review and Meta-analysis of Therapeutic Interventions.
    Tchero H; Herlin C; Bekara F; Fluieraru S; Teot L
    Indian J Dermatol Venereol Leprol; 2019; 85(3):248-257. PubMed ID: 30924446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hidradenitis suppurativa, a review of pathogenesis, associations and management. Part 2.
    Vekic DA; Cains GD
    Australas J Dermatol; 2018 Nov; 59(4):261-266. PubMed ID: 29363099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Update of hidradenitis suppurativa in Primary Care].
    García-Martínez FJ; Pascual JC; López-Martín I; Pereyra-Rodríguez JJ; Martorell Calatayud A; Salgado-Boquete L; Labandeira-García J
    Semergen; 2017; 43(1):34-42. PubMed ID: 26874678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A retrospective review of light- and laser-based management of hidradenitis suppurativa.
    Levoska MA; Nicholson CL; Hamzavi IH
    Semin Cutan Med Surg; 2017 Jun; 36(2):67-74. PubMed ID: 28538747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive approach to managing hidradenitis suppurativa patients.
    Collier EK; Hsiao JL; Shi VY; Naik HB
    Int J Dermatol; 2020 Jun; 59(6):744-747. PubMed ID: 32250448
    [No Abstract]   [Full Text] [Related]  

  • 14. Systematic Review of Light-Based Treatments for Hidradenitis Suppurativa.
    Gracia Cazaña T; Berdel Díaz LV; Martín Sánchez JI; Querol Nasarre I; Gilaberte Y
    Actas Dermosifiliogr (Engl Ed); 2020 Mar; 111(2):89-106. PubMed ID: 31870491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hidradenitis suppurativa.
    Jemec GB
    J Cutan Med Surg; 2003; 7(1):47-56. PubMed ID: 12457209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactive, Proof of Concept Clinical Trial Design in Hidradenitis Suppurativa.
    Gottlieb AB
    J Invest Dermatol; 2021 Feb; 141(2):431-433. PubMed ID: 32585209
    [No Abstract]   [Full Text] [Related]  

  • 17. Reliability of the hidradenitis suppurativa clinical response in the assessment of patients with hidradenitis suppurativa.
    Kimball AB; Ganguli A; Fleischer A
    J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2254-2256. PubMed ID: 29959796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inter-rater agreement and reliability of outcome measurement instruments and staging systems used in hidradenitis suppurativa.
    Thorlacius L; Garg A; Riis PT; Nielsen SM; Bettoli V; Ingram JR; Del Marmol V; Matusiak L; Pascual JC; Revuz J; Sartorius K; Tzellos T; van der Zee HH; Zouboulis CC; Saunte DM; Gottlieb AB; Christensen R; Jemec GBE
    Br J Dermatol; 2019 Sep; 181(3):483-491. PubMed ID: 30724351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bayesian analysis of hierarchical pattern-mixture models for clinical trials data with attrition and comparisons to commonly used ad-hoc and model-based approaches.
    Demirtas H
    J Biopharm Stat; 2005; 15(3):383-402. PubMed ID: 15920887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine Pathways and Investigational Target Therapies in Hidradenitis Suppurativa.
    Del Duca E; Morelli P; Bennardo L; Di Raimondo C; Nisticò SP
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33182701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.